A detailed history of Capital International, Inc. transactions in Grifols Sa stock. As of the latest transaction made, Capital International, Inc. holds 200,697 shares of GRFS stock, worth $1.69 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
200,697
Previous 200,718 0.01%
Holding current value
$1.69 Million
Previous $2.32 Million 42.24%
% of portfolio
0.02%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$5.47 - $11.38 $114 - $238
-21 Reduced 0.01%
200,697 $1.34 Million
Q4 2023

Feb 13, 2024

BUY
$7.71 - $11.56 $134,971 - $202,369
17,506 Added 9.56%
200,718 $2.32 Million
Q3 2023

Nov 13, 2023

BUY
$8.91 - $10.91 $171,303 - $209,755
19,226 Added 11.72%
183,212 $1.67 Million
Q2 2023

Aug 11, 2023

BUY
$7.14 - $9.29 $7,996 - $10,404
1,120 Added 0.69%
163,986 $1.5 Million
Q1 2023

May 15, 2023

BUY
$6.65 - $10.69 $12,029 - $19,338
1,809 Added 1.12%
162,866 $1.2 Million
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.53 $51,917 - $74,304
8,711 Added 5.72%
161,057 $1.37 Million
Q3 2022

Nov 14, 2022

SELL
$5.95 - $14.3 $371,065 - $891,805
-62,364 Reduced 29.05%
152,346 $938,000
Q2 2022

Aug 15, 2022

SELL
$10.6 - $13.28 $39,315 - $49,255
-3,709 Reduced 1.7%
214,710 $2.55 Million
Q1 2022

May 16, 2022

SELL
$10.37 - $12.73 $927,285 - $1.14 Million
-89,420 Reduced 29.05%
218,419 $2.55 Million
Q3 2021

Nov 15, 2021

SELL
$14.07 - $17.3 $417,555 - $513,412
-29,677 Reduced 8.79%
307,839 $4.5 Million
Q2 2021

Aug 16, 2021

SELL
$16.62 - $18.94 $113,863 - $129,757
-6,851 Reduced 1.99%
337,516 $5.86 Million
Q1 2021

May 14, 2021

BUY
$15.15 - $19.78 $605,394 - $790,408
39,960 Added 13.13%
344,367 $5.95 Million
Q4 2020

Feb 16, 2021

BUY
$16.86 - $19.67 $910,558 - $1.06 Million
54,007 Added 21.57%
304,407 $5.61 Million
Q3 2020

Nov 13, 2020

BUY
$15.4 - $20.16 $3.86 Million - $5.05 Million
250,400 New
250,400 $4.34 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.71B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Capital International, Inc. Portfolio

Follow Capital International, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.